MicroRNA biomarkers for periodontitis with and without diabetes

Summarised from:

MicroRNA-146a and microRNA-155 as novel crevicular fluid biomarkers for periodontitis in non-diabetic and type 2 diabetic patients
(Journal of Clinical Periodontology; doi: 10.1111/jcpe.12888)

Authors:

Nikola Radović, Nataša Nikolić Jakoba, Nina Petrović, Aleksandra Milosavljević, Božidar Brković, Jelena Roganović

Summarised by:

Dr Varkha Rattu

Research Topic:

Background + Aims

  • MicroRNAs are small RNA molecules that regulate gene expression, influencing processes such as inflammation and antioxidant defence. Their presence in gingival crevicular fluid (GCF) may provide information about local periodontal disease and the influence of diabetes.
  • This study aimed to:
    • Assess whether GCF levels of miR-146a and miR-155 were associated with periodontitis, type 2 diabetes and response to periodontal treatment, and to explore their relationship with antioxidant activity.

Materials + Methods

  • The study included 96 adults, divided into four groups of 24 participants: periodontal health without diabetes, periodontal health with type 2 diabetes, periodontitis without diabetes, and periodontitis with type 2 diabetes.
  • Participants with diabetes had been diagnosed for at least 2-years and had HbA1c below 8%. Smokers and people with other systemic diseases were excluded.
  • Full-mouth examinations measured probing pocket depth, clinical attachment level, bleeding on probing, plaque and gingival inflammation.
  • GCF was collected from 2 sites per participant. Quantitative real-time PCR measured microRNA expression, while laboratory testing assessed superoxide dismutase (SOD), an enzyme that helps neutralise reactive oxygen species.
  • Participants with periodontitis received oral hygiene instruction, scaling and root planing, with reassessment 6-weeks after treatment.
  • Statistical analyses examined associations after adjusting for age and sex. ROC curves assessed how well each marker distinguished periodontitis from periodontal health.

Results

  • Both miR-146a and miR-155 were significantly elevated in participants with periodontitis, whether or not they had diabetes. Associations remained significant after adjustment for age and sex.
  • Both markers decreased to levels comparable with the corresponding periodontally healthy groups, alongside improvements in clinical periodontal measurements.
  • Higher levels of both microRNAs correlated with deeper periodontal pockets in participants with and without diabetes.
  • Among periodontally healthy participants, miR-146a was higher in those with type 2 diabetes than in those without diabetes.
  • In participants without diabetes, miR-146a achieved an AUC of 0.999, with 100% sensitivity and 96% specificity. In participants with diabetes, miR-155 performed best, with an AUC of 0.988, 92% sensitivity and 100% specificity.
    • Sensitivity indicates detection of affected participants
    • Specificity indicates correct identification of healthy participants.
  • Antioxidant association – SOD activity was elevated in periodontitis, positively correlated with both microRNAs and decreased after treatment.

Limitations

  • The small, selected sample limits generalisability, particularly to smokers and people with HbA1c ≥8%.
  • Periodontitis groups were substantially older than healthy controls, despite statistical adjustment.
  • Diagnostic thresholds were developed and assessed in the same sample, without independent validation, potentially overstating performance.
  • 6-week follow-up without an untreated periodontitis comparison group limits conclusions about treatment effects and long-term monitoring.
  • Serum microRNA levels were not measured, leaving their relationship with systemic diabetes-related changes uncertain.

Conclusion

  • GCF miR-146a and miR-155 showed promise as markers of periodontal disease and treatment response in people with and without type 2 diabetes.
  • Larger, independently validated studies are needed before these measurements can be considered reliable clinical diagnostic or monitoring tools.
Read the full article Back to Research

Research  |  15.05.18

clock icon 5 mins to read

Share this page:

Copy Link

You might also like...

Events

Periodontitis-Diabetes Hub x #DiabetesChat

Hosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.

Read more

Events

Oral Health Challenges Among People Living With Diabetes

Dr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on…

Read more

Events

Periodontitis-Diabetes Hub x #DiabetesChat

Hosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.

Read more

Events

Oral Health Challenges Among People Living With Diabetes

Dr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on the relationship between diabetes and oral health.

Read more
icon1 services

Periodontitis is the 6th most prevalent condition globally

icon1 services

Periodontitis and diabetes are bidirectionally linked

icon1 services

Diabetic complications are increased if you have both diseases

icon1 services

Successful periodontal treatment can improve blood glucose control

icon1 services

Periodontitis is the 6th most prevalent condition globally

icon1 services

Periodontitis and diabetes are bidirectionally linked

icon1 services

Diabetic complications are increased if you have both diseases

icon1 services

Successful periodontal treatment can improve blood glucose control

Our Team

Team - The Periodontitis-Diabetes Hub

Dr Varkha Rattu

Founder & Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Amar Puttanna

Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Rajeev Raghavan

Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Mark Ide

Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Luigi Nibali

Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Dominika Antoniszczak

Education & Support Advisor

Team - The Periodontitis-Diabetes Hub

Dr Jasmine Loke

Clinical Content Advisor

Team - The Periodontitis-Diabetes Hub

Dr Mira Shah

Patient Resource Advisor

Team - The Periodontitis-Diabetes Hub

Elaine Tilling

Outreach & Communications Lead

Team - The Periodontitis-Diabetes Hub

Dr Varkha Rattu

Periodontitis-Diabetes Hub Position: Founder & Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Amar Puttanna

Periodontitis-Diabetes Hub Position: Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Rajeev Raghavan

Periodontitis-Diabetes Hub Position: Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Mark Ide

Periodontitis-Diabetes Hub Position: Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Luigi Nibali

Periodontitis-Diabetes Hub Position: Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Dominika Antoniszczak

Periodontitis-Diabetes Hub Position: Education and Support Advisor

Team - The Periodontitis-Diabetes Hub

Dr Jasmine Loke

Periodontitis-Diabetes Hub Position: Clinical Content Advisor

Team - The Periodontitis-Diabetes Hub

Dr Mira Shah

Periodontitis-Diabetes Hub Position: Patient Resource Advisor

Team - The Periodontitis-Diabetes Hub

Elaine Tilling

Periodontitis-Diabetes Hub Position: Outreach and Communications Lead

View All